Derm-Biome’s DB-007-5 reduces itch in preclinical model of atopic dermatitis
Feb. 27, 2025
Derm-Biome Pharmaceuticals Inc. has reported findings from a study of its topical drug DB-007-5 in a well-established preclinical model of human atopic dermatitis.